Immunocore (IMCR) Net earnings per share growth forecast for next year

Symbol and logo of brand Immunocore PLC (IMCR)

Exclusive patents and stringent FDA oversight create a powerful defensive moat for Immunocore Holdings plc (IMCR). The GURU.Markets interface displays a projection of the company's profit dynamics for the coming year, where the value of -105.70 corresponds to the current metric. Innovative developments in T-cell receptors enable the destruction of tumors, while management's expertise ensures the effective scaling of these scientific breakthroughs across the global market.

IMCR - Immunocore PLC Earnings growth forecast for next year over the range 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Immunocore PLC (IMCR)

- price and consensus price forecast:
Analysis of all company metrics:Immunocore PLC
Core merchandise of Immunocore Holdings

For Immunocore Holdings plc (IMCR), whose revenues depend on passing stringent FDA and EMA filters, this indicator reflects the market consensus regarding the commercialization of proprietary T-cell technologies. By analyzing the projected earnings per share (EPS) growth benchmark, an investor can see the aggregated trend of expected net income per security, which allows for an assessment of the company's capitalization potential while accounting for regulatory risks.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year januxrx.com (JANX)|Net earnings per share growth forecast for next year Arcus Biosciences Inc (RCUS)|Expected earnings per share growth for next year Zymeworks Corp ZYME|Tango Therapeutics Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Iovance Corp IOVA|IMTX - Net earnings per share growth forecast for next year|XNCR (xencor.com) - Projected earnings per share growth rate for next year|Compass Therapeutics Corp (CMPX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Replimune Corp (REPL)|Expected earnings per share growth for next year LYEL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech)|Expected earnings per share trend next year STRO|minktherapeutics.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics, Inc.|Immix (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Cue Biopharma|Earnings growth forecast for next year pdsbiotech.com|Net earnings per share growth forecast for next year sonnetbio.com (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year